Tarnjot Kaur

Tarnjot Kaur

Auto-generated profile, based on publicly available information

Tarnjot Kaur

Department of Pharmaceutical Sciences, School of Health Science and Technology, UPES, 248007 Dehradun, Uttarakhand, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Heliyon
Verified
Journal Article
Open access
TKTarnjot Kaur
Tarnjot Kaur
JUJyoti Upadhyay
Jyoti Upadhyay
MNMukesh Nandave
Mukesh Nandave
AAAbdulrhman Alsayari
Abdulrhman Alsayari
SASaad Ali Alshehri
Saad Ali Alshehri
Mohd Nazam AnsariMohd Nazam Ansari
Mohd Nazam Ansari
Anemia is a severe health issue that affects around one-third of the global population. Therefore, the present study aims to conduct a bibliometric analysis to investigate the research trends regarding advancements on iron formulations in treating iron deficiency anemia via oral or parenteral route. This study adopts thematic and bibliometric methods on existing research on novel iron formulations. It also provides perspective into the existing understanding on treatment strategies for iron deficiency anemia. This study is conducted on 543 papers on various ferrous and ferric formulations used in the treatment of iron deficiency anemia. The study period is from 1977 to 2022, and the papers are identified from the Scopus database. The bibliometric analysis was carried out using the R tool's Bibliometrix package. The study discusses performance analysis, including annual publications, geographic analysis, relevant affiliations, journal analysis, and citation analysis. In addition, the conceptual structure, including the co-occurrence network, thematic map, thematic evolution, intellectual structure highlighting co-citation analysis, and social structure depicting the collaboration network and collaboration world map, are presented. The results showed increased research on formulation strategies for the treatment of iron deficiency anemia from 2010 onwards. The top 5 contributing countries are the USA, Italy, India, Germany, and the UK, and peer-reviewed journals from the area of nutrition. The most trending areas of study are iron deficiency anemia in pregnancy, chronic kidney diseases, inflammatory bowel diseases, and various intravenous formulations used in its treatment. The authors from Europe collaborate the most with authors from other countries. The study concludes that a safer and more effective iron formulation is needed to reduce the prevalence of anemia. The findings of the study are helpful in advancing research on innovative formulations for treating iron deficiency anemia. The insights from the study are helpful to policymakers in designing specific health policies and investing more in research and development of novel formulations for the treatment of iron deficiency anemia.

19 March 2025 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
TKTarnjot Kaur
Tarnjot Kaur
NHNikita Hinge
Nikita Hinge
SPSudeep Pukale
Sudeep Pukale
Mohd Nazam AnsariMohd Nazam Ansari
Mohd Nazam Ansari
KTKamal Yoonus Thajudeen
Kamal Yoonus Thajudeen
JUJyoti Upadhyay
Jyoti Upadhyay
Psoriasis has been a rising concern for over a decade, imposing significant challenges to individuals and society. Traditional topical therapy is non-targeted and acts systemically, with associated side effects. This increases the global burden both socially and economically. This review covers the evolution of drug molecules and nanotechnology-based approaches for the topical treatment of psoriasis, a chronic inflammatory skin disorder with no known etiology. Nanotechnology-based approaches offer promising solutions by reducing side effects, providing targeted delivery, protecting drug molecules from degradation, enhancing skin retention, and providing controlled release. Researchers have investigated the incorporation of various conventional and non-conventional therapeutic agents into nanocarriers for psoriasis treatment. The current understanding of the disease and its treatment using various therapeutic agents combined with novel formulation strategies will reduce the duration of treatment and improve the quality of life in psoriatic disease conditions.